Next Article in Journal
Variability in Arterial Stiffness and Vascular Endothelial Function After COVID-19 During 1.5 Years of Follow-Up—Systematic Review and Meta-Analysis
Previous Article in Journal
Antimicrobial Investigation of Phthalimide and N-Phthaloylglycine Esters: Activity, Mechanism of Action, Synergism and Ecotoxicity
Previous Article in Special Issue
A Pilot Randomized Controlled Trial (RCT) Evaluating the Efficacy of an Exosome-Containing Plant Extract Formulation for Treating Male Alopecia
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

In Vitro Anti-Glioblastoma Activity of Echinocereus engelmannii- and Echinocereus pectinatus-Associated Bacterial Endophyte Extracts

by
Ana L. Delgado-Miranda
1,
Ricardo Gomez-Flores
1,*,
Nancy E. Rodríguez-Garza
1,2,
Orquídea Pérez-González
1,
Patricia Tamez-Guerra
1,
Diana Caballero-Hernández
1,
Diana L. Clark-Pérez
1,
Ramiro Quintanilla-Licea
3,
Andrés García
4 and
César I. Romo-Sáenz
1,5,*
1
Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, Mexico
2
Grupo de Enfermedades Infecciosas y Tropicales (e-INTRO), Facultad de Farmacia, Instituto de Investigación Biomédica de Salamanca-Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (IBSAL-CIETUS), Universidad de Salamanca, 37007 Salamanca, Spain
3
Departamento de Química, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, Mexico
4
Laboratorio de Biotecnología Ambiental, Centro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Morelos, Mexico
5
Facultad de Medicina y Ciencias Biomédicas, Universidad Autónoma de Chihuahua, Chihuahua 31109, Chihuahua, Mexico
*
Authors to whom correspondence should be addressed.
Life 2025, 15(4), 519; https://doi.org/10.3390/life15040519
Submission received: 6 February 2025 / Revised: 15 March 2025 / Accepted: 17 March 2025 / Published: 21 March 2025
(This article belongs to the Special Issue Implications of Bioactive Compounds in Lifelong Disorders)

Abstract

:
Glioblastoma is the most common and aggressive brain tumor in adults. However, due to the limitations of conventional treatments, as well as their side effects, there is a need to develop more effective and less harmful therapy strategies. There is evidence that plants endemic to northern Mexico possess biological activities that positively impact human health, particularly against cancer. Echinocereus engelmannii and Echinocereus pectinatus are cacti from the north of Mexico that produce bioactive compounds with antitumor activity. We obtained methanol extracts from previously isolated and fermented microorganisms associated with these cacti. Cell lines of extracts with cytotoxicity against glioblastoma cells U87, neuroblastoma cells SH-S5Y5, and Schwann neuronal cells (healthy control) were evaluated, using a colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazole bromide (MTT) reduction technique. The selective cytotoxicity extracts were analyzed using liquid chromatography tandem mass spectrometry (LC/MS2). We isolated 19 endophytic and soil-associated microorganisms from both cacti. Two of them were selected for their high percentages of tumor growth inhibition. The microorganism ES4 possessed the best activity with an IC50 of 17.31 ± 1.70 µg/mL and a selectivity index of 3.11. We identified the bacterium Stenotrophomonas maltophilia by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) from the most active microorganisms against tumor growth. LC/MS2 characterized the HS4 extract, and the most abundant group (50.0%) identified included carboxylic acids and derivatives, particularly bisgerayafolin A, Cyclo (Pro-Leu), maculosin, and tryptophan. In conclusion S. maltophilia extract inhibit the growth of glioma cells, showing greater sensitivity in the U87 cell line.

1. Introduction

Cancer is the leading cause of death worldwide, representing the 10th most common cause of death, with gliomas being the most prevalent type of malignant brain tumors. The first symptoms in adults are not specific, involving headaches, seizures, and vision problems, among others, making timely diagnosis difficult [1]. Although multiple treatments have been developed against this type of disease, the death rate remains at 9,743,832 deaths per year and is estimated to increase to 16,884,723 by 2045 [2]. This is due to the resistance to currently existing drugs and the high rate of mutations of diverse types of cancer. In Mexico in 2018, central nervous system (CNS) tumors were the 17th in cancer incidence with 3451 cases and the 13th in cancer deaths [3].
Glioblastoma is a tumor that directly affects the CNS and is considered the most common and aggressive brain tumor in adults [4]. Globally, 248,500 deaths from this type of cancer were estimated in 2022, and by 2045, a 54.1% increase in the mortality rate is expected [2]. Current treatment consists of complete surgical removal of the tumor followed by a combination of chemotherapy and radiotherapy [5]. However, the difficulty of a timely diagnosis, as well as the resistance to the most commonly used chemotherapeutics such as temozolomide [6] are related to the development of more aggressive cancers, directly impacting patient survival or increasing tumor regression in most patients. Due to the different mechanisms of resistance to treatments and the high rate of mutations in glioblastoma, the search for new cancer treatments is a constant challenge [7].
Mexican plants have been used as traditional remedies for different health conditions and have shown to possess anticancer potential and less toxicity compared with conventional therapies [8,9]. In recent years, various agents have been isolated and used in the treatment of distinct types of cancer, including vinblastine, vincristine, podophyllotoxin, paclitaxel (Taxol), and camptothecin, which have been extensively studied both chemically and clinically [10].
Cacti are promising producers of anticancer molecules due to their potential to grow under extreme climate and water scarcity environments. Consequently, they create natural defenses such as phytochemicals, including alkaloids, flavonoids, terpenes, and tannins, potentially generated by endophytic microorganisms, which possess relevant bioactivities against cancer [8,9].
Within the Cactaceae family, there is evidence of several highly studied species, such as Opuntia spp., which, besides being a food of great nutritional importance, possesses anticancer, antioxidant, anti-inflammatory, antiviral, and antidiabetic potential. These bioactivities have been observed in both stem and fruit extracts of these species, which demonstrated good effectiveness in different in vitro and in vivo models [11].
An important antioxidant activity has been observed in species of Echinocereus, as well as a high content of phenolic compounds, such as quercetin and isorhamnetin, along with their derivatives, protocatechuic acid and apigenin [9]. It has been shown that quercetin induces apoptosis in liver cancer tumor cells (HepG2) when different flavonoid concentrations are added. Higher doses of these substances were shown to induce cell death through increased activation of caspases 3 and 9, as well as inhibition of the AKT kinase protein and the phosphorylation of the ERK kinase protein. In addition, they produced an increase in the pro-apoptotic factors Bcl-2 and a decrease in the anti-apoptotic Bcl-XL [12].
Endophytic or rhizosphere microorganisms from plants have gained relevance as potential sources for identifying new compounds with antitumor activity. Their rapid growth, culture conditions, high cell density, easy genetic manipulation, and the possibility of scaling up the production of compounds to an industrial level make them potential candidates for obtaining anticancer drugs with significant efficiency [13]. There are several reports on the biological activity of endophytic microorganisms, particularly those associated with Lophocereus marginatus, such as Aspergillus versicolor and Metarhizium anisopliae, as well as endophytic microorganisms from Ibervillea sonorae, including Micromonospora echinospora and Bacillus subtilis, have demonstrated anticancer activity in both in vivo and in vitro murine lymphoma models [13,14,15].
The present study aimed to determine the in vitro antitumor potential of endophytic microorganism extracts from the cacti Echinocereus engelmanni (Parry ex Engelm.) Lem. and E. pectinatus (Scheidw.) Engelm. against glioblastoma.

2. Materials and Methods

2.1. Plant Material

The mature size cacti Echinocereus engelmanni and E. pectinatus used in this study were obtained from the greenhouse “Vivero Ortiz” in Chihuahua, Chihuahua, México on August 21, 2021. Taxonomic identification of the plant was performed at the herbarium of the Facultad de Ciencias Biológicas of the Universidad Autónoma de Nuevo León (FCB-UANL), with a voucher number 25608 for E. pectinatus and 25607 for E. engelmanii.
Taxonomic validation of plant names and families was performed using the International Plant Names Index (https://www.ipni.org/; accessed on 2 March 2025).

2.2. Isolation of Endophytic Microorganisms from E. engelmannii and E. pectinatus

Endophytic microorganisms from the cactus body stem and soil-associated root were isolated through the following steps. The root was washed with soap and water and internal cuts of 1 cm2 were made, followed by 1-min washes in 1% NaClO and sterile distilled water, a 1-min treatment with 70% ethanol, two consecutive 1-min rinses with sterile distilled water, and a final wash with PBS solution (negative control), all under sterile conditions in a biosafety level 2 laminar-flow hood. Disinfected root pieces were incubated on potato dextrose agar plates (PDA; Titan biotech LTD, Bhiwadi, India) for two weeks at 28 °C ± 2 °C. The plant tissue was then macerated in 9 mL of PBS, using a sterile mortar, and 100 μL of the macerate were plated on PDA and incubated for two weeks at 28 °C ± 2 °C. Isolated colonies (colonies began to form after 10 days) were stored in PDB with 30% glycerol at −70 °C, until use [15].
We isolated 19 endophytic (E) and soil-associated (S) microorganisms, including three soil-associated microorganisms (HS1, HS4, and HS5) and two endophytes (HE1 and HE2) from Echinocereus engelmannii, and 10 soil-associated microorganisms (ES4 to ES13) and four endophytes (EE1 to EE4) from E. pectinatus.

2.3. Methanol Extracts Preparation and Fermentation of Endophytic Microorganisms from E. engelmannii and E. pectinatus

Nineteen microorganisms were isolated from the cacti and fermented, after which methanol extracts were obtained. For this, pieces of two weeks PDA-cultured endophytic microorganisms agar (2 cm2 pieces) were obtained and placed in flasks with 150 mL of potato dextrose broth (PDB; BD, Becton, Dickinson and Company, Sparks, MD, USA), which were statically fermented at 28 °C ± 2 °C for three weeks. The biomass obtained was then filtered through filter paper, and methanol was added and kept under agitation for 48 h at 28 °C ± 2 °C. Next, extracts were filtered and concentrated by rotary evaporation with a vacuum rotary evaporator (Buchi R-3000; Brinkman Instruments, Inc., Westbury, NY, USA). The residual solvent was removed with a SpeedVac concentrator (Thermo Fisher Scientific, San Jose, CA, USA) at 35 °C [8,9]. The extraction yield was calculated using the following formula: % Yield = (weight of dry extracts/weight of vegetal material) × 100. Next, 100 mg of each extract was dissolved in one milliliter of dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO, USA), sterilized by filtration, using 0.22 μm pore size membrane filters (Corning Incorporated, Corning, NY, USA), and stored at −20 °C until use. The final concentration of DMSO used in cell cultures was less than 1% (v/v), which did not affect cell viability [13].

2.4. Cell Lines and Culture Conditions

In this study, we used the glioblastoma cells U87 (ATCC HTB-14), neuroblastoma cells SH-S5Y5 (ATCC CRL-2266), and Schwann neuronal cells (ATCC CRL-3392; healthy control). They were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich), supplemented with 10% fetal bovine serum (FBS; Grand Island, NY, USA) that was previously heat-inactivated and 1% antibiotic antimycotic solution (Sigma-Aldrich, St. Louis, MO, USA) at 37 °C and 5% CO2 in a humidified atmosphere.

2.5. Effect of E. engelmannii and E. pectinatus-Associated Endophytes on Tumor Cell Growth

We incubated 190 µL of U87, SH-S5Y5, and Schwann cell suspensions (1 × 104 cells/well) in DMEM medium in 96-well flat-bottomed microplates (Corning Incorporated) for 24 h, after which we added the methanol extracts at concentrations of 31.25 µg/mL to 250 µg/mL for an initial selection. We used paclitaxel at 0.1 µM (0.0854 µg/mL) as a positive control and culture medium without treatment as a negative control. Next, culture plates were incubated for 48 h at 37 °C and 5% CO2 in a humid atmosphere. Cell viability was then determined by the colorimetric 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide (MTT; Affymetrix, Cleveland, OH, USA) method by adding 15 µL of MTT (0.5 mg/mL final concentration) to each well and incubating for three hours at 37 °C and 5% CO2. After this, plates were decanted, and 100 µL of DMSO were added to dissolve formazan crystals. Optical densities (OD) were then measured at 570 nm in a microplate reader (MULTISKAN GO; Thermo Fisher Scientific, Waltham, MA, USA). The percentage of growth inhibition was determined by the following formula: % Growth inhibition = 100 − (OD570 treated cells/OD570 untreated cells) × 100.
Based on the results obtained, we selected the two microorganism extracts with the highest growth inhibition percentage (HS4 and ES4). Concentrations ranging from 1 µg/mL to 250 µg/mL were evaluated. We then used the growth inhibition concentration-response curve to calculate the half-maximal inhibitory concentration (IC50) and the selectivity index (SI) of each extract using the following formula: SI = IC50 normal cells (Schwann cells)/IC50 tumor cells (U87 and SH-S5Y5 cells).

2.6. Antioxidant Activity

We also evaluated the antioxidant activity of HS4 and ES4. For this, we incubated 100 μL of the extracts in 96-well flat-bottomed plates at concentrations ranging from 3.9 µg/mL to 250 µg/mL and 100 μL of a 0.1 mM methanol solution of 2,2-diphenyl-1-picrylhydrazyl (DPPH) at 28 °C ± 2 °C for 30 min in darkness, using DMSO as the negative control and 10 μg/mL to 100 μg/mL ascorbic acid as the positive control. ODs were then read at 517 nm in a Genesys 20 spectrophotometer (Thermo-Fisher Scientific, Waltham, MA, USA). DPPH reduction percentage was calculated using the following formula: % DPPH reduction = [(OD517 negative control − OD517 treatment)/OD517 negative control] × 100 [15].

2.7. Hemolytic Activity Test

The in vitro hemolysis test is used to evaluate the toxicity of a variety of products in the pharmaceutical industry to be applied in the clinic. We then determined the hemolytic activity of HS4 and ES4. For this test, we obtained 20 mL of blood from a healthy volunteer in BD Vacutainer EDTA tubes (Becton Dickinson, Franklin Lakes, NJ, USA), after which blood was centrifuged to separate erythrocytes from plasma at 1500 rpm (15 min at 25 °C) and washed three times with 10 mL of PBS (pH 7.4). Erythrocytes were then suspended at 5% v/v in PBS for the hemolytic activity test, for which this suspension was mixed with the extracts dissolved in PBS at concentrations ranging from 200 μg/mL to 1000 μg/mL in 2 mL Eppendorf (Eppendorf® AG, Hamburg, Germany) microcentrifuge tubes for 30 min at 37 °C in darkness, using distilled water as a positive control and PBS as a negative control. Samples were incubated for 30 min at 37 °C, after which they were centrifuged for five minutes at 13,000 rpm and 4 °C. Next, 200 µL of supernatant fluids were obtained from each tube and transferred to 96-well flat-bottomed plates to measure the OD of the released hemoglobin at 540 nm in a microplate reader [16]. The percentage of hemolysis was calculated using the following formula: % Hemolysis = [(OD540 treatment − OD540 negative control)/(OD540 positive control − OD540 negative control)] × 100.

2.8. Identification of Selected Strains

HS4 and ES4 strains were sent to the Infectious Diseases Laboratory of the University Hospital “Dr. José Eleuterio González”, Autonomous University of Nuevo Leon, Mexico, where they were identified via matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Microflex LT System, BrukerDaltonics, Bremen, Germany), using the MALDI Biotyper 3.0 software.

2.9. Characterization of Methanol Extracts of Selected Microorganisms

Extract characterization was performed in the Metabolomics and Proteomics Specialized Laboratory (MetPro) of Ensenada, Baja California, Mexico, using liquid chromatography-tandem mass spectrometry (LC/MS2).
We chose the HS4 extract as it exhibited the highest activity in the U87 cell line. For the analysis, the HS4 methanol extract was suspended in a water-acetonitrile mixture (80:20) and injected (2 μL or 600 ng) into an Agilent 1260 Infinity LC (Agilent Technologies, Inc., Santa Clara, CA, USA). The LC/MS2 analysis followed the protocol previously described.
For MS data acquisition, positive mode nanospray ionization was used with the following conditions: capillary voltage (1850 V), gas temperature (350 °C), drying gas flow (5 L/min), skimmer voltage (65 V), octapole RF (750 V), fragmentor voltage (175 V), and spectra acquisition rate (4 spectra/s) over a mass range of 110–2000 m/z. For MS2 data, a narrow isolation window (1.3 m/z), spectra acquisition rate (3 spectra/s), and a maximum of 5 precursors per cycle in the 50–2000 m/z range were applied. Active exclusion was enabled for two spectra with a release time of 0.25 min. Collision energy was ramped with slope and offset values of 6 and 4, respectively.
The LC/MS2 datasets were analyzed using open-access software and online platforms. The Global Natural Products Social Molecular Networking web platform (GNPS, https://gnps.ucsd.edu, accessed on 5 March 2023) was used for automated structural analysis. Additionally, the CSI:FingerID package from SIRIUS software version 4.9.12 (https://bio.informatik.uni-jena.de/software/sirius/, accessed on 5 March 2023) was employed as a complementary tool. The chemical classes of the identified metabolites were automatically determined using the Classyfire web-based application (http://classyfire.wishartlab.com, accessed on 10 March 2023) [16].

2.10. Statistical Analysis

Statistical analyses were performed using the Graph Pad Prism 8 program (GraphPad Software Inc., San Diego, CA, USA). A nonlinear regression analysis was used to calculate the half maximal inhibitory concentration (IC50) values. All data represent means ± standard deviations (SD) of triplicate determinations from three independent experiments.

3. Results

3.1. Isolation of Microorganisms and Extraction Yields

We isolated nineteen endophytic (E) and soil-associated (S) microorganisms. Endophytic microorganisms were isolated from the body stem of the cactus and soil-associated with roots. These microorganisms include three soil-associated microorganisms (HS1, HS4, and HS5) and two endophytes (HE1 and HE2) from E. engelmannii, and ten soil-associated microorganisms (ES4 to ES13) and four endophytes (EE1 to EE4) from E. pectinatus, whose yields are shown in Table 1.

3.2. Effect of Extracts on Tumor Cell Growth

We initially evaluated 31.25 µg/mL and 250 µg/mL of microorganism extracts to select those with the highest activity against U87 (Figure 1) and SH-S5Y5 (Figure 2) cells. We found that ES4 and HS4 possessed the highest growth inhibition activity.
As HS4 and ES4 microorganisms extracts showed the highest inhibition activity concentration-related growth response curves were produced with these microorganisms extracts to obtain the IC50 and SI. The IC50 and SI results of the extracts from the microorganisms ES4 and HS4 against the U87 and SH-S5Y5 cell lines are shown in Table 2 and Table 3, respectively. Results for ES4 showed a higher antitumor potential in the SH-S5Y5 cell line with an IC50 of 17.31 µg/mL, compared to the U87 cell line with an IC50 of 45.11 µg/mL. The microorganism extract HS4 showed a higher antitumor potential in the U87 cell line with an IC50 of 87.66 µg/mL compared to the SH-S5Y5 cell line with an IC50 of 117.90 µg/mL.

3.3. Antioxidant and Hemolytic Activities

Extracts of the two microorganisms extracts with the highest antitumor activity were selected to evaluate their antioxidant and hemolytic activities. They showed IC50 > 250 µg/mL, thus indicating marginal antioxidant or hemolytic activities (Table 4).

3.4. Identification of Selected Microorganisms

The selected microorganisms were identified using mass spectrometry (MALDI-TOF) (Table 5). Both microorganisms were identified as Stenotrophomonas maltophilia with a different score for each strain: 1.93 for HS4 and 1.54 for ES4.

3.5. Characterization of Methanol Extracts

The extract produced by the microorganism HS4 was characterized by LC/MS2. Three main groups of bioactive compounds were found, the most abundant being carboxylic acids and derivatives (50.0%), followed by glycerophospholipids (33.33%) and indoles and derivatives (16.67%). Specifically, 12 metabolites were identified as cyclo (Pro-Val), Lyso PE (16:0/0:0), N-fructosyl isoleucine, PE (15:0/16:0), PE (16:0/14:0), PE (16:0/16:1), Fen-Pro, pyroglutamylproline, bisgerayafolin A, cyclo (Pro-Leu), maculosin, and tryptophan (Table 6). Structure of compound with biological activity reported are shown in Figure 3.

4. Discussion

Glioblastoma is the most common brain tumor in adults [17] surgical removal, followed by chemotherapy with temozolomide (C6H6N6O2), in combination with radiotherapy [18]. Temozolomide is the chemotherapeutic agent of choice against glioblastoma. It is a dacarbazine derivative that presents alkylating activity. It shows relatively good therapeutic efficacy but presents several side effects [19]. Despite this treatment, most tumors are incurable and highly recurrent because conventional therapies are not usually effective against tumor cells and damage healthy cells [19]. This has led to the search for new alternative approaches, such as the use of natural products. In this context, there are natural compounds obtained from cacti such as opuntiol, macdougallin, and peniocerol, which have shown significant antitumor potential [20,21]. However, in recent years it has been shown that in certain cases, the antitumor activity of plants is provided by endophytic microorganisms [22]. Therefore, in the present study we investigated the antitumor potential of crude methanol extracts obtained from endophytic microorganisms of Echinocereus engelmannii and E. pectinatus.
Nineteen microorganisms with different morphological characteristics were isolated. We obtained up to 6.30% crude methanol extract yields from these microorganisms, which were higher than those obtained from our previous study using endophytes isolated from the cactus Ibervillea sonorae, with up to 3.5% [15]. The antitumor effect of these microorganisms was subsequently evaluated, showing higher activity against the SH-S5Y5 cell line as compared with that against the U87 cell line. This has been previously reported, where the bacoside compound extracted from the plant Bacopa monniera caused 60% SH-S5Y5 growth inhibition [22], and may be due to the presence of new mutations and oncogenic expressions for drug resistance in different models of human glioblastoma and that resistance to the drug temozolomide has also been observed in the U87 cell line, resulting in treatment failure [23].
Of the 19 microorganism extracts evaluated, HE1, HS4, and ES4 presented the highest antitumor activity, with a growth inhibition >80% in both glioblastoma cell lines. These results highlight the importance of evaluating the antitumor potential of endophytic microorganisms against other cancer cell lines, such as U87, but we have not found evidence of the evaluation of plant-derived endophytic microorganism extracts against glioblastoma. Regarding the HS4 extract, a higher growth inhibition was observed against the cell line SH-S5Y5 (IC50 = 87.66 ± 1.54 µg/mL) than that against the U87 cell line (IC50 = 117.90 ± 1.99 µg/mL) and an SI of 1.30 for the SH-S5Y5 cell line, as compared with 1.75 for the U87 cell line. Furthermore, the ES4 microorganism extract caused an IC50 of 17.31 ± 1.73 µg/mL against the SH-S5Y5 cell line and an IC50 of 45.11 ± 1.87 against the U87 cell line, with an SI of 3.11 for the SH-S5Y5 cell line and 1.19 for the U87 cell line. SI > 2 indicating that an extract has pharmacological potential to continue with the fractionation and identify the presence of the compound or compounds responsible for the antitumor activity [24] and a low cellular toxicity to normal cells [25].
In addition, HS4 and ES4 microorganisms extracts showed DPPH values IC50 > 250 µg/mL. Extracts with an IC50 ≤ 50 µg/mL are considered to have relevant antioxidant activity, thus these extracts do not possess antioxidant potential [13,26]. Regarding the hemolysis analysis, the extracts of both microorganisms showed IC50 values > 250 µg/mL, thus they did not have significant hemolysis [27].
HS4 and ES4 microorganisms were identified by MALDI-TOF, determining that they corresponded to the species Stenotrophomonas maltohpilia. This species is associated with plants and has been isolated from the rhizosphere or the internal tissues of plants [28]. Moreover, endophytic strains of S. maltophilia have been isolated from the roots of many plant species, which possess an extraordinary range of activities, including plant protection and growth promotion, bioremediation, phytoremediation, and the production of biomolecules of significant economic value [29].
Since the HS4 miscoorganism extract presented the highest antitumor activity against U87 cells, it was characterized by LC/MS2. The analysis showed a major composition of carboxylic acids and their derivatives. These are commonly used as cancer therapies, as well as to prevent the side effects of radiotherapy [30]. This chemical group has also been described in the endophytic bacteria of rice, demonstrating antifungal activity [31] a high percentage of glycerophospholipids, often used as supplements to restore cellular functions, improve mitochondrial membrane potential, and increase resistance to oxidative stress [32]. Another group identified were indoles and derivatives. It has been shown that several indole-based compounds may have high potential in cancer treatments [33].
In addition, we identified 12 metabolites from HS4 microorganisms extract, among which bisgerayafolin A. It has been reported to have cytotoxic and antioxidant activity, and its presence has been found in plants such as Murraya koenigii; however, there is no report on its production by endophytes [34]. Carbazoles, the group to which bisgerayafolin A belongs, possess antimicrobial, anti-inflammatory, antitumor, antihistamine, analgesic, antitumor, and neuroprotective properties [35]. Another important compound identified in the extract was maculosin, which has been used as an antibacterial and antioxidant agent and is also produced by the fungus Alternaria [36,37]. Furthermore, this compound has cytotoxic activity against human liver cancer, which is why it is proposed as a compound with a high therapeutic value [38]. Moreover, the dipeptide Cyclo (Pro-Leu) has been shown to have antifungal and antimicrobial activities [39]; tryptophan has been involved in the regulation of immunity, neuronal function, and intestinal homeostasis [40] N-fructosyl isoleucine has been reported to possess antifungal, plant growth regulating, and cell signaling activity, but its antitumor activity has not been investigated [41,42]. The biological activity of the compounds PE (15:0/16:0), PE (16:0/14:0), PE (16:0/16:1), Fen-Pro, and pyroglutamylproline have not yet been elucidated.
However, it is necessary to perform a biotargeted fractionation to isolate and identify the bioactive compounds with antitumoral activity. Additionally, it would be essential to assess the compounds in an in vivo murine model to confirm their antitumoral activity and exclude any potential toxicity.

5. Conclusions

These results demonstrate the antitumor effect of methanolic extracts obtained from S. maltophilia associated with E. engelmannii and E. pectinatus, showing significant cytotoxic activity against human glioblastoma cells. Methanolic extracts of S. maltophilia are proposed for the study and isolation of new compounds with antitumor activity.

Author Contributions

Conceptualization, A.L.D.-M. and C.I.R.-S.; methodology, A.L.D.-M. and C.I.R.-S.; validation, R.G.-F., C.I.R.-S., D.C.-H. and P.T.-G.; formal analysis, A.L.D.-M., D.L.C.-P. and C.I.R.-S.; investigation, A.L.D.-M. and C.I.R.-S.; resources, R.G.-F., C.I.R.-S., D.C.-H., P.T.-G., O.P.-G., A.G. and R.Q.-L.; data curation, A.L.D.-M.; writing—original draft preparation, A.L.D.-M.; writing—review and editing, R.G.-F., C.I.R.-S. and N.E.R.-G.; visualization, C.I.R.-S.; supervision, R.G.-F. and C.I.R.-S.; project administration, R.G.-F. and C.I.R.-S.; funding acquisition, R.G.-F. and C.I.R.-S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Consejo Nacional de Humanidades, Ciencia y Tecnología (CONAHCYT, México), CVU: 1179485 to A.L.D.-M., CVU: 1006989 to N.E.R.-G., CVU: 1179478 to D.L.C-P., and CVU: 445572 to C.I.R-S.

Institutional Review Board Statement

The procedures in this study were approved by the Ethics Committee of the Facultad de Ciencias Biolόgicas (FCB) at the Universidad Autόnoma de Nuevo Leόn (UANL) on 22 April 2022, under registration number CI-09-2022. Experiments involving human erythrocytes were conducted with the informed consent of a healthy donor and in compliance with the Official Mexican Technical Standard NOM-253-SSA1-2012.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The datasets generated or analyzed during the present study are available from the corresponding authors.

Acknowledgments

The authors thank the CONHACYT of Mexico.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. McKinnon, C.; Nandhabalan, M.; Murray, S.A.; Plaha, P. Glioblastoma: Clinical Presentation, Diagnosis, and Management. BMJ 2021, 374, n1560. [Google Scholar] [CrossRef] [PubMed]
  2. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar]
  3. INEGI. Estadísticas de Defunciones Registradas (EDR). 2024. Available online: https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2024/EDR/EDR2024_1erT.pdf (accessed on 6 February 2025).
  4. Wirsching, H.-G.; Galanis, E.; Weller, M. Glioblastoma. In Handbook of Clinical Neurology; Elsevier: Amsterdam, The Netherlands, 2016; Volume 134, pp. 381–397. [Google Scholar]
  5. Yin, W.; Wang, J.; Jiang, L.; Kang, Y.J. Cancer and Stem Cells. Exp. Biol. Med. 2021, 246, 1791–1801. [Google Scholar] [CrossRef]
  6. Mittal, S.; Ali, J.; Baboota, S. Overcoming the Challenges in the Treatment of Glioblastoma via Nanocarrier- Based Drug Delivery Approach. Curr. Pharm. Des. 2021, 27, 4539–4556. [Google Scholar] [CrossRef]
  7. Aasland, D.; Götzinger, L.; Hauck, L.; Berte, N.; Meyer, J.; Effenberger, M.; Schneider, S.; Reuber, E.E.; Roos, W.P.; Tomicic, M.T.; et al. Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR–CHK1, P21, and NF-ΚB. Cancer Res. 2019, 79, 99–113. [Google Scholar] [CrossRef] [PubMed]
  8. Harlev, E.; Nevo, E.; Solowey, E.; Bishayee, A. Cancer Preventive and Curative Attributes of Plants of the Cactaceae Family: A Review. Planta Med. 2013, 79, 713–722. [Google Scholar] [CrossRef] [PubMed]
  9. Pensamiento-Niño, C.A.; Campos-Montiel, R.G.; Añorve-Morga, J.; Ramírez-Moreno, E.; Ascacio-Valdés, J.A.; Hernández-Fuentes, A.D. Nutritional Characterization of the Functional and Antioxidant Activity of Cactus Flowers from Hidalgo, Mexico. Appl. Sci. 2021, 11, 5965. [Google Scholar] [CrossRef]
  10. Gezici, S.; Şekeroğlu, N. Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents. Anticancer Agents Med. Chem. 2019, 19, 101–111. [Google Scholar] [CrossRef]
  11. Salazar, J.R.; Loza-Mejía, M.A.; Soto-Cabrera, D. Chemistry, Biological Activities and In Silico Bioprospection of Sterols and Triterpenes from Mexican Columnar Cactaceae. Molecules 2020, 25, 1649. [Google Scholar] [CrossRef]
  12. Vicente-Vicente, L.; Prieto, M.; Morales, A. Eficacia y Seguridad de La Quercetina Como Complemento Alimenticio. Rev. Toxicol. 2013, 30, 171–181. [Google Scholar]
  13. Ramírez-Villalobos, J.M.; Romo-Sáenz, C.I.; Morán-Santibañez, K.S.; Tamez-Guerra, P.; Quintanilla-Licea, R.; Orozco-Flores, A.A.; Romero-Arguelles, R.; Tamez-Guerra, R.; Rodríguez-Padilla, C.; Gomez-Flores, R. In Vitro Tumor Cell Growth Inhibition Induced by Lophocereus marginatus (DC.) S. Arias and Terrazas Endophytic Fungi Extracts. Int. J. Environ. Res. Public Health 2021, 18, 9917. [Google Scholar] [CrossRef] [PubMed]
  14. Clark-Pérez, D.L.; Romo-Sáenz, C.I.; Ramírez-Villalobos, J.M.; Tamez-Guerra, P.; Caballero-Hernández, D.; Delgado-Miranda, A.L.; García, A.; Elizondo-Luevano, J.H.; Rodríguez-Padilla, C.; Gomez-Flores, R. In Vitro and In Vivo Antitumor Activity of Lophocereus marginatus (DC.) S. Arias & Terrazas Endophytic Aspergillus versicolor and Metarhizium anisopliae Extracts Against the Murine Lymphoma L5178Y-R. Microorganisms 2024, 12, 2310. [Google Scholar] [CrossRef]
  15. Romero-Arguelles, R.; Romo-Sáenz, C.I.; Morán-Santibáñez, K.; Tamez-Guerra, P.; Quintanilla-Licea, R.; Orozco-Flores, A.A.; Ramírez-Villalobos, J.M.; Tamez-Guerra, R.; Rodríguez-Padilla, C.; Gomez-Flores, R. In Vitro Antitumor Activity of Endophytic and Rhizosphere Gram-Positive Bacteria from Ibervillea sonorae (S. Watson) Greene against L5178Y-R Lymphoma Cells. Int. J. Environ. Res. Public Health 2022, 19, 894. [Google Scholar] [CrossRef] [PubMed]
  16. Rodríguez-Garza, N.E.; Gomez-Flores, R.; Quintanilla-Licea, R.; Elizondo-Luévano, J.H.; Romo-Sáenz, C.I.; Marín, M.; Sánchez-Montejo, J.; Muro, A.; Peláez, R.; López-Abán, J. In Vitro Anthelmintic Effect of Mexican Plant Extracts and Partitions Against Trichinella spiralis and Strongyloides venezuelensis. Plants 2024, 13, 3484. [Google Scholar] [CrossRef]
  17. Majc, B.; Novak, M.; Kopitar-Jerala, N.; Jewett, A.; Breznik, B. Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development. Cells 2021, 10, 265. [Google Scholar] [CrossRef] [PubMed]
  18. Le Rhun, E.; Preusser, M.; Roth, P.; Reardon, D.A.; van den Bent, M.; Wen, P.; Reifenberger, G.; Weller, M. Molecular Targeted Therapy of Glioblastoma. Cancer Treat. Rev. 2019, 80, 101896. [Google Scholar] [CrossRef]
  19. Jezierzański, M.; Nafalska, N.; Stopyra, M.; Furgoł, T.; Miciak, M.; Kabut, J.; Gisterek-Grocholska, I. Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes. Curr. Oncol. 2024, 31, 3994–4002. [Google Scholar] [CrossRef] [PubMed]
  20. Ashfaque, A.; Hanif, F.; Simjee, S.; Bari, M.; Faizi, S.; Zehra, S.; Mirza, T.; Begum, S.; Khan, L. Opuntiol Inhibits Growth and Induces Apoptosis in Human Glioblastoma Cells by Upregulating Active Caspase 3 Expression. Asian Pac. J. Cancer Prev. 2021, 22, 3607–3613. [Google Scholar] [CrossRef]
  21. Salazar, J.R.; Martínez-Vazquez, M.; Cespedes, C.L.; Ramírez-Apan, T.; Nieto-Camacho, A.; Rodríguez-Silverio, J.; Flores-Murrieta, F. Anti-Inflammatory and Cytotoxic Activities of Chichipegenin, Peniocerol, and Macdougallin Isolated from Myrtillocactus geometrizans (Mart. Ex Pfeiff.) Con. Z. Naturforschung C 2011, 66, 24–30. [Google Scholar] [CrossRef]
  22. Malishev, R.; Shaham-Niv, S.; Nandi, S.; Kolusheva, S.; Gazit, E.; Jelinek, R. Bacoside-A, an Indian Traditional-Medicine Substance, Inhibits β-Amyloid Cytotoxicity, Fibrillation, and Membrane Interactions. ACS Chem. Neurosci. 2017, 8, 884–891. [Google Scholar] [CrossRef]
  23. Nagpal, I.; Yuan, Z.M. The Basally Expressed P53-Mediated Homeostatic Function. Front. Cell Dev. Biol. 2021, 9, 775312. [Google Scholar] [CrossRef]
  24. Indrayanto, G.; Putra, G.S.; Suhud, F. Validation of In-Vitro Bioassay Methods: Application in Herbal Drug Research. In Profiles of Drug Substances, Excipients and Related Methodology; Academic Press: Cambridge, MA, USA, 2021; Volume 46, pp. 273–307. [Google Scholar] [CrossRef]
  25. Mansour, K.A.; El-Neketi, M.; Lahloub, M.-F.; Elbermawi, A. Nanoemulsions of Jasminum Humile L. and Jasminum Grandiflorum L. Essential Oils: An Approach to Enhance Their Cytotoxic and Antiviral Effects. Molecules 2022, 27, 3639. [Google Scholar] [CrossRef] [PubMed]
  26. La Cruz-Jiménez, L.D.; Hernández-Torres, M.A.; Monroy-García, I.N.; Rivas-Morales, C.; Verde-Star, M.J.; Gonzalez-Villasana, V.; Viveros-Valdez, E. Biological Activities of Seven Medicinal Plants Used in Chiapas, Mexico. Plants 2022, 11, 1790. [Google Scholar] [CrossRef]
  27. Rodríguez-Garza, N.E.; Quintanilla-Licea, R.; Romo-Sáenz, C.I.; Elizondo-Luevano, J.H.; Tamez-Guerra, P.; Rodríguez-Padilla, C.; Gomez-Flores, R. In Vitro Biological Activity and Lymphoma Cell Growth Inhibition by Selected Mexican Medicinal Plants. Life 2023, 13, 958. [Google Scholar] [CrossRef]
  28. Ryan, R.P.; Monchy, S.; Cardinale, M.; Taghavi, S.; Crossman, L.; Avison, M.B.; Berg, G.; van der Lelie, D.; Dow, J.M. The Versatility and Adaptation of Bacteria from the Genus Stenotrophomonas. Nat. Rev. Microbiol. 2009, 7, 514–525. [Google Scholar] [CrossRef]
  29. Elshafie, H.S.; Camele, I. An Overview of Metabolic Activity, Beneficial and Pathogenic Aspects of Burkholderia spp. Metabolites 2021, 11, 321. [Google Scholar] [CrossRef] [PubMed]
  30. Bian, X.; Qian, Y.; Tan, B.; Li, K.; Hong, X.; Wong, C.C.; Fu, L.; Zhang, J.; Li, N.; Wu, J.-L. In-Depth Mapping Carboxylic Acid Metabolome Reveals the Potential Biomarkers in Colorectal Cancer through Characteristic Fragment Ions and Metabolic Flux. Anal. Chim. Acta 2020, 1128, 62–71. [Google Scholar] [CrossRef] [PubMed]
  31. Radhakrishnan, N.A.; Ravi, A.; Joseph, B.J.; Jose, A.; Jithesh, O.; Krishnankutty, R.E. Phenazine 1-Carboxylic Acid Producing Seed Harbored Endophytic Bacteria from Cultivated Rice Variety of Kerala and Its Broad Range Antagonism to Diverse Plant Pathogens. Probiotics Antimicrob. Proteins 2023, 15, 516–523. [Google Scholar] [CrossRef]
  32. Medica, A.J.; Aitken, R.J.; Nicolson, G.L.; Sheridan, A.R.; Swegen, A.; De Iuliis, G.N.; Gibb, Z. Glycerophospholipids Protect Stallion Spermatozoa from Oxidative Damage in Vitro. Reprod. Fertil. 2021, 2, 199–209. [Google Scholar] [CrossRef]
  33. Jadoon, M.S.K.; Pelletier, J.; Sévigny, J.; Iqbal, J. Synthesis of New Class of Indole Acetic Acid Sulfonate Derivatives as Ectonucleotidases Inhibitors. RSC Adv. 2023, 13, 29496–29511. [Google Scholar] [CrossRef]
  34. Uvarani, C.; Sankaran, M.; Jaivel, N.; Chandraprakash, K.; Ata, A.; Mohan, P.S. Bioactive Dimeric Carbazole Alkaloids from Murraya koenigii. J. Nat. Prod. 2013, 76, 993–1000. [Google Scholar] [CrossRef]
  35. Grande, F.; Ioele, G.; Caruso, A.; Occhiuzzi, M.A.; El-Kashef, H.; Saturnino, C.; Sinicropi, M.S. Carbazoles: Role and Functions in Fighting Diabetes. Appl. Sci. 2022, 13, 349. [Google Scholar] [CrossRef]
  36. Paudel, B.; Maharjan, R.; Rajbhandari, P.; Aryal, N.; Aziz, S.; Bhattarai, K.; Baral, B.; Malla, R.; Bhattarai, H.D. Maculosin, a Non-Toxic Antioxidant Compound Isolated from Streptomyces sp. KTM18. Pharm. Biol. 2021, 59, 931–934. [Google Scholar] [CrossRef]
  37. Wang, H.; Guo, Y.; Luo, Z.; Gao, L.; Li, R.; Zhang, Y.; Kalaji, H.M.; Qiang, S.; Chen, S. Recent Advances in Alternaria Phytotoxins: A Review of Their Occurrence, Structure, Bioactivity, and Biosynthesis. J. Fungi 2022, 8, 168. [Google Scholar] [CrossRef]
  38. Karanam, G.; Arumugam, M.K.; Natesh, N.S. Anticancer Effect of Marine Sponge-Associated Bacillus pumilus AMK1 Derived Dipeptide Cyclo (-Pro-Tyr) in Human Liver Cancer Cell Line Through Apoptosis and G2/M Phase Arrest. Int. J. Pept. Res. Ther. 2020, 26, 445–457. [Google Scholar] [CrossRef]
  39. Yan, P.-S.; Song, Y.; Sakuno, E.; Nakajima, H.; Nakagawa, H.; Yabe, K. Cyclo (l-leucyl-l-prolyl) Produced by Achromobacter xylosoxidans Inhibits Aflatoxin Production by Aspergillus parasiticus. Appl. Environ. Microbiol. 2004, 70, 7466–7473. [Google Scholar] [CrossRef]
  40. Platten, M.; Nollen, E.A.A.; Röhrig, U.F.; Fallarino, F.; Opitz, C.A. Tryptophan Metabolism as a Common Therapeutic Target in Cancer, Neurodegeneration and Beyond. Nat. Rev. Drug Discov. 2019, 18, 379–401. [Google Scholar] [CrossRef]
  41. National Center for Biotechnology Information PubChem Compound Summary for CID 131752725, N-(1-Deoxy-1-Fructosyl)Isoleucine. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/N-_1-Deoxy-1-fructosyl_isoleucine (accessed on 14 December 2024).
  42. National Center for Biotechnology Information PubChem Compound Summary for CID 6992261, Cyclo(L-Pro-L-Val). Available online: https://pubchem.ncbi.nlm.nih.gov/compound/cyclo_L-Pro-L-Val (accessed on 14 December 2024).
Figure 1. Effect of microorganism extracts on U87 cell growth. Paclitaxel was used as a positive control at a concentration of 0.1 µM (0.0854 µg/mL), causing 80% growth inhibition, and cells without treatment as a negative control.
Figure 1. Effect of microorganism extracts on U87 cell growth. Paclitaxel was used as a positive control at a concentration of 0.1 µM (0.0854 µg/mL), causing 80% growth inhibition, and cells without treatment as a negative control.
Life 15 00519 g001
Figure 2. Effect of microorganism extracts on SH-SY5Y cell growth. Paclitaxel was used as a positive control at a concentration of 0.1 µM (0.0854 µg/mL), causing 65% growth inhibition, and cells without treatment as a negative control.
Figure 2. Effect of microorganism extracts on SH-SY5Y cell growth. Paclitaxel was used as a positive control at a concentration of 0.1 µM (0.0854 µg/mL), causing 65% growth inhibition, and cells without treatment as a negative control.
Life 15 00519 g002
Figure 3. Metabolites present in the HS4 methanol extract with biological activity reported.
Figure 3. Metabolites present in the HS4 methanol extract with biological activity reported.
Life 15 00519 g003
Table 1. Methanol extracts yield from microorganisms associated with E. engelmannii and E. pectinatus.
Table 1. Methanol extracts yield from microorganisms associated with E. engelmannii and E. pectinatus.
MicroorganismYield (%)
ES41.17
ES50.79
ES60.67
ES76.30
ES80.77
ES92.73
ES101.46
ES110.90
ES120.50
ES130.56
EE10.36
EE21.34
EE30.79
EE42.70
HE10.67
HE20.57
HS10.71
HS43.63
HS50.56
Table 2. Antitumoral activity of HS4 and ES4 extracts against U87 cell line.
Table 2. Antitumoral activity of HS4 and ES4 extracts against U87 cell line.
MicroorganismIC50 (µg/mL)SI
Schwan
Healthy Cell Line
U87
Tumoral Cell Line
HS4152.80 ± 2.2087.66 ± 1.541.75
ES453.87 ± 1.7345.11 ± 1.871.19
Data are mean ± SD of the IC50 (µg/mL) for each extract against Schwan and U87 cells at 72 h. SI represents IC50 of Schwan cells divided by IC50 of U87 cells at 72 h. Paclitaxel was used as a positive control at 0.0854 µg/mL.
Table 3. Antitumoral activity of HS4 and ES4 extracts against SH-S5Y5 cell line.
Table 3. Antitumoral activity of HS4 and ES4 extracts against SH-S5Y5 cell line.
MicroorganismIC50 (µg/mL)SI
Schwan
Healthy Cell Line
SH-S5Y5
Tumoral Cell Line
HS4152.80 ± 2.20117.90 ± 1.991.30
ES453.87 ± 1.7317.31 ± 1.733.11
Data are mean ± SD of the IC50 (µg/mL) for each extract against Schwan and SH-S5Y5 cells at 72 h. SI represents IC50 of Schwan cells divided by IC50 of SH-S5Y5 cells at 72 h. Paclitaxel was used as a positive control at 0.0854 µg/mL.
Table 4. Antioxidant and hemolytic activities of ES4 and HS4 extracts.
Table 4. Antioxidant and hemolytic activities of ES4 and HS4 extracts.
MicroorganismIC50 (μg/mL)
DPPHHemolysis
HS4>250>250
ES4>250>250
Table 5. Identification of selected strains by MALDI-TOF.
Table 5. Identification of selected strains by MALDI-TOF.
MicroorganismStrainScore
HS4Stenotrophomonas maltophilia1.93
ES4Stenotrophomonas maltophilia1.54
Score: Numerical scoring for the interpretation of MALDI-TOF results. A score ≥ 1.80 indicates a high confidence level in accurate identification.
Table 6. LC/MS2 compounds in HS4 extract.
Table 6. LC/MS2 compounds in HS4 extract.
No.CompoundExperimental MassTheoretical MassAdductMass Error (ppm)FormulaRTChemical Class
1N-Fructosyl isoleucine294.155294.155[M + H]+1.18C12H23NO71.3CAD
2Pyroglutamylproline227.103227.103[M + H]+1.95C10H14N2O41.7CAD
3Tryptophan205.096205.097[M + H]+−5.25C11H12N2O23.2IND
4Maculosin261.123261.123[M + H]+−1.12C14H16N2O33.4CAD
5Cyclo(Pro-Val)197.128197.128[M + H]+−1.92C10H16N2O23.8CAD
6Cyclo(Pro-Leu)211.144211.144[M + H]+−0.13C11H18N2O28.8CAD
7Phe-Pro245.129245.129[M − H2O + H]+−0.01C14H18N2O310.9CAD
8Lyso PE(16:0/0:0)454.293454.293[M + H]+0.57C21H44NO7P26.4GPL
9Bisgerayafoline A815.486815.478[M + H]+9.62C55H62N2O428.8IND
10PE(15:0/16:0)678.507678.507[M + H]+0.36C36H72NO8P28.8GPL
11PE(16:0/14:0)664.492664.491[M + H]+1.35C35H70NO8P29GPL
12PE(16:0/16:1)690.505690.507[M + H]+−2.54C37H72NO8P29.8GPL
RT: Retention time in minutes; CAD: Carboxylic acids and derivatives; IND: Indoles and derivatives; GPL: Glycerophospholipids.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Delgado-Miranda, A.L.; Gomez-Flores, R.; Rodríguez-Garza, N.E.; Pérez-González, O.; Tamez-Guerra, P.; Caballero-Hernández, D.; Clark-Pérez, D.L.; Quintanilla-Licea, R.; García, A.; Romo-Sáenz, C.I. In Vitro Anti-Glioblastoma Activity of Echinocereus engelmannii- and Echinocereus pectinatus-Associated Bacterial Endophyte Extracts. Life 2025, 15, 519. https://doi.org/10.3390/life15040519

AMA Style

Delgado-Miranda AL, Gomez-Flores R, Rodríguez-Garza NE, Pérez-González O, Tamez-Guerra P, Caballero-Hernández D, Clark-Pérez DL, Quintanilla-Licea R, García A, Romo-Sáenz CI. In Vitro Anti-Glioblastoma Activity of Echinocereus engelmannii- and Echinocereus pectinatus-Associated Bacterial Endophyte Extracts. Life. 2025; 15(4):519. https://doi.org/10.3390/life15040519

Chicago/Turabian Style

Delgado-Miranda, Ana L., Ricardo Gomez-Flores, Nancy E. Rodríguez-Garza, Orquídea Pérez-González, Patricia Tamez-Guerra, Diana Caballero-Hernández, Diana L. Clark-Pérez, Ramiro Quintanilla-Licea, Andrés García, and César I. Romo-Sáenz. 2025. "In Vitro Anti-Glioblastoma Activity of Echinocereus engelmannii- and Echinocereus pectinatus-Associated Bacterial Endophyte Extracts" Life 15, no. 4: 519. https://doi.org/10.3390/life15040519

APA Style

Delgado-Miranda, A. L., Gomez-Flores, R., Rodríguez-Garza, N. E., Pérez-González, O., Tamez-Guerra, P., Caballero-Hernández, D., Clark-Pérez, D. L., Quintanilla-Licea, R., García, A., & Romo-Sáenz, C. I. (2025). In Vitro Anti-Glioblastoma Activity of Echinocereus engelmannii- and Echinocereus pectinatus-Associated Bacterial Endophyte Extracts. Life, 15(4), 519. https://doi.org/10.3390/life15040519

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop